Rebecca A Lew

Title: Rebecca A Lew: Innovator in Neuroactive Peptides

Introduction

Rebecca A Lew is a prominent inventor based in Port Melbourne, Australia. She has made significant contributions to the field of neuroactive peptides, showcasing her expertise and innovative spirit. Her work has implications for understanding and modulating neuronal activity, which is crucial for various therapeutic applications.

Latest Patents

Rebecca A Lew holds a patent for the invention titled "LV V-Haemorphin-7 neuroactive peptide and methods of use." This invention relates to neuroactive peptides or analogues that possess at least one of the biological activities of angiotensin IV. The peptide sequence involved is Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe. The patent outlines methods for modulating neuronal activity and includes pharmaceutical compositions that utilize these peptides.

Career Highlights

Rebecca is affiliated with the Howard Florey Institute of Experimental Physiology, where she conducts her research. Her work at this esteemed institution has allowed her to explore the complexities of neuroactive peptides and their potential applications in medicine.

Collaborations

Rebecca has collaborated with notable colleagues, including Frederick A O Mendelsohn and Siew Yeen Chai. These collaborations have enriched her research and contributed to advancements in the understanding of neuroactive peptides.

Conclusion

Rebecca A Lew is a trailblazer in the field of neuroactive peptides, with her innovative patent contributing to the understanding of neuronal activity. Her work at the Howard Florey Institute and collaborations with esteemed colleagues further highlight her impact in the scientific community.